OMICS ANALYSIS II
RNA-SEQ
APPLICATIONS OF RNA-SEQ
IDENTIFICATION AND QUANTIFICATION
ATAGACCGCGATA
Gene
Identification
Alignment
Quantification
COULD WE COMPARE THEM?
| S.1 |
Gene 1 | 3 |
| S.1 |
Gene 1 | 33 |
33-3=30
COULD WE COMPARE THEM?
| S.1 |
Gene 1 | 3 |
Gene 2 | 5 |
Gene 3 | 0 |
Gene 4 | 8 |
Gene 5 | 1 |
Gene 6 | 4 |
| S.1 |
Gene 1 | 33 |
Gene 2 | 23 |
Gene 3 | 3 |
Gene 4 | 43 |
Gene 5 | 10 |
Gene 6 | 5 |
All are higher
COULD WE COMPARE THEM?
| S.1 | S.2 | S.3 |
Gene 1 | 3 | 4 | 3 |
Gene 2 | 5 | 7 | 10 |
Gene 3 | 0 | 0 | 0 |
Gene 4 | 8 | 4 | 8 |
Gene 5 | 1 | 2 | 2 |
Gene 6 | 4 | 4 | 5 |
| S.1 | S.2 | S.3 |
Gene 1 | 33 | 3 | 5 |
Gene 2 | 23 | 3 | 8 |
Gene 3 | 3 | 0 | 1 |
Gene 4 | 43 | 4 | 4 |
Gene 5 | 10 | 1 | 2 |
Gene 6 | 5 | 5 | 7 |
S.1 has significant higher quantification
COULD WE COMPARE THEM?
| S.1 | S.2 | S.3 |
Gene 1 | 3 | 4 | 3 |
Gene 2 | 5 | 7 | 10 |
Gene 3 | 0 | 0 | 0 |
Gene 4 | 8 | 4 | 8 |
Gene 5 | 1 | 2 | 2 |
Gene 6 | 4 | 4 | 5 |
| S.1 | S.2 | S.3 |
Gene 1 | 23 | 23 | 25 |
Gene 2 | 3 | 3 | 8 |
Gene 3 | 3 | 0 | 1 |
Gene 4 | 4 | 4 | 4 |
Gene 5 | 2 | 1 | 2 |
Gene 6 | 6 | 5 | 7 |
Prot.1 has significant higher quantification
COULD WE COMPARE THEM?
| S.1 | S.2 | S.3 |
Gene 1 | 3 | 4 | 3 |
Gene 2 | 5 | 7 | 10 |
Gene 3 | 0 | 0 | 0 |
Gene 4 | 8 | 4 | 8 |
Gene 5 | 1 | 2 | 2 |
Gene 6 | 4 | 4 | 5 |
| S.1 | S.2 | S.3 |
Gene 1 | 23 | 3 | 5 |
Gene 2 | 3 | 3 | 8 |
Gene 3 | 3 | 0 | 1 |
Gene 4 | 4 | 4 | 4 |
Gene 5 | 2 | 1 | 2 |
Gene 6 | 6 | 5 | 7 |
Prot.1 at S.1 has significant higher quantification
NORMALIZATION
NORMALIZATION
NORMALIZATION
RPKM
NORMALIZATION
RPKM
Divided by the sum of counts within the sample
RPKM
Divided by exon length
FPKM
Gene
Only count as 1
TPM
Divided by the gene length
TPM
Divided by the sum of counts within the sample from 1 step
COMPARING RPKM AND TPM
CORRELATION COEFFICIENT
CORRELATION COEFFICIENT
CORRELATION COEFFICIENT OR�EUCLIDEAN DISTANCE
Correlation coefficient is based on the trend. In this case, the correlation coefficient will be nearly 100%.
Euclidean distance is based on the distance between two lines. In this case, Euclidean distance is still not small.
The key is “the amount is matter or not”.
QUANTIFICATION COMPARISON
DIFFERENTIAL EXPRESSION ANALYSIS
HER2 receptor
HER2 receptor
WHEN ARE TWO VALUES DIFFERENT
REPLICATES INCREASE RELIABILITY
FOLD CHANGE NOT INFORMATIVE ENOUGH
T-TEST
P-VALUE
MULTIPLE HYPOTHESIS PROBLEM
Individual p–values are no significant findings
BENJAMINI-HOCHBERG CORRECTION
Test if:
34
Rank i | P-value | Adjusted significance level | ? Reject H0 |
1 | 0.00002 | 0.001 | yes |
2 | 0.00013 | 0.002 | yes |
3 | 0.00034 | 0.003 | yes |
4 | 0.00087 | 0.004 | yes |
5 | 0.001 | 0.005 | yes |
6 | 0.0054 | 0.006 | yes |
7 | 0.009 | 0.007 | no |
8 | 0.01 | 0.008 | no |
9 | 0.023 | 0.009 | no |
10 | 0.4 | 0.01 | no |
Significance Level:
Adjusted Significance Level
PERMUTATION-BASED FDR
Compute test statistic & p-value
Permute data
Repeat many times
Control
Stimulus
Control
Stimulus
Compute test statistic & p-value
Protein A
Protein B
Protein C
Protein D
Protein E
MEASURED
PERMUTED
Careful with technical replicates !!!
VOLCANO PLOT
FDR cutoff at
Sign. Level 0.05
LogFC
-Log(q)
USING FOLD CHANGE
Difference
-log p
-log p
Difference
LogFC
-Log(q)
-Log(q)
LogFC
VOLCANO PLOT
The normal cutoff is
Q-value ≤ 0.05 which means
-log(q-value) ≥ ~1.3
Log2(FC) ≥ 1 ~ 2 or Log2(FC) ≤ -1 ~ -2
ENRICHMENT ANALYSIS
Contingency table:
In pathway?
Significant ?
| yes | no |
yes | 15 | 849 |
no | 12 | 3,657 |
Is a particular pathway overrepresented in the set
of differentially expressed proteins?
Difference
-log p
Fatty acid metabolism
Significant
Non Significant
ENRICHMENT ANALYSIS
Difference
-log p
Fatty acid metabolism
Significant
Non Significant
Category column | Category value | Total size | Selection size | Category size | Intersection size | Enrichment factor | P value | Benj. Hoch. FDR |
KEGG name | Fatty acid elongation in mitochondria | 4533 | 864 | 6 | 6 | 5.25 | 4.73E-05 | 2.42E-03 |
KEGG name | Benzoate degradation | 4533 | 864 | 8 | 7 | 4.59 | 5.81E-05 | 2.48E-03 |
GOCC name | organellar ribosome | 4533 | 864 | 15 | 12 | 4.20 | 5.25E-07 | 4.36E-05 |
GOCC name | mitochondrial ribosome | 4533 | 864 | 15 | 12 | 4.20 | 5.25E-07 | 4.76E-05 |
KEGG name | Valine, leucine and isoleucine degradation | 4533 | 864 | 35 | 22 | 3.30 | 1.17E-08 | 3.00E-06 |
GOBP name | cellular hormone metabolic process | 4533 | 864 | 21 | 13 | 3.25 | 1.56E-05 | 1.92E-03 |
GOBP name | fatty acid catabolic process | 4533 | 864 | 32 | 19 | 3.12 | 4.18E-07 | 1.09E-04 |
KEGG name | Butanoate metabolism | 4533 | 864 | 16 | 9 | 2.95 | 8.46E-04 | 1.55E-02 |
KEGG name | Fatty acid metabolism | 4533 | 864 | 27 | 15 | 2.91 | 2.06E-05 | 1.32E-03 |
Contingency table:
In pathway?
Significant ?
| yes | no |
yes | 15 | 849 |
no | 12 | 3,657 |
Enrichment analysis on categorical data
LogFC
-Log(q)
ENRICHMENT ANALYSIS
MULTIPLE SAMPLE TEST
1D ANNOTATION ENRICHMENT
All proteins
Do ribosomal proteins show preferentially higher abundances compared to all proteins?
0
200
400
600
800
12
Log2 (Protein intensities)
28
32
16
20
24
Ribosomal proteins
1D ANNOTATION ENRICHMENT
Enrichment analysis on numerical data
All proteins
0
200
400
600
800
12
Log2 (Protein intensities)
28
32
16
20
24
Ribosomal proteins
Score = 2(R1-R2)/n = 0.85
EXAMPLE OF PCA
PRINCIPLE COMPONENT ANALYSIS
PCA – Linear model
tSNE – Non-linear model
UMAP – non-linear model
CO-EXPRESSION ANALYSIS
DIMENSIONALITY REDUCTION METHOD
CLUSTERING HEATMAP
SPLICE EVENT
GENE FUSION
NON-CODING RNA
NON-CODING RNA
EQTL:EXPRESSION QUANTITATIVE TRAIT LOCI ANALYSIS
RIBOSOME PROFILING
APPLICATION OF RIBO-SEQ
DE NOVO SEQUENCING
5. Using close species to generate annotations.
PALEO-GENOMICS